Ignite Creation Date:
2024-05-06 @ 7:17 PM
Last Modification Date:
2024-10-26 @ 3:03 PM
Study NCT ID:
NCT05955508
Status:
RECRUITING
Last Update Posted:
2024-06-10
First Post:
2023-07-13
Brief Title:
A Proof-of-Concept Trial to Study the Safety and Activity of Linvoseltamab in Participants With Smoldering Multiple Myeloma at High Risk of Developing Multiple Myeloma
Sponsor:
Organization:
Regeneron Pharmaceuticals